Trial Profile
A phase II, single-center, randomized, controlled, observer-blind study to determine the non-inferiority of a topical mometasone formulation vs a marketed comparator by evaluation of the anti-psoriatic efficacy in a psoriasis plaque test.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Almirall Hermal GmbH
- 05 Aug 2011 New trial record